Asia Pacific Veterinary Healthcare Market Industry: Market Size & Forecast 2026

The Asia Pacific Veterinary Healthcare Market covers a broad range of products including veterinary drugs, vaccines, medicated feed additives, and diagnostic equipment used in both companion animal care and livestock management. The market is valued at approximately $11.5 billion in 2025 and is experiencing steady expansion driven by diverse regional economies from Japan and Australia to China, India, and Southeast Asian nations. Growth is underpinned by increasing animal health awareness among pet owners and livestock producers across the region.

• •Market valued at approximately $11.5 billion in 2025 with an annual growth rate of 8.14%
• •Covers companion animals (dogs, cats) and livestock (cattle, poultry, swine, aquaculture species)
• •Includes pharmaceuticals, vaccines, diagnostics, and feed additives

Rapid urbanization and rising disposable incomes across emerging markets like China, India, and Southeast Asia have fueled increased spending on companion animal healthcare, including routine vaccinations, parasite control, and premium pet food. Concurrently, growing demand for protein-rich diets has expanded commercial livestock production, driving demand for veterinary medicines and disease management solutions. Government initiatives to control zoonotic diseases and improve animal health standards also contribute significantly to market expansion.

• •Growing middle class and pet humanization trends boosting companion animal healthcare spending
• •Rising protein consumption driving demand for livestock health products and feed additives
• •Government and regulatory emphasis on controlling zoonotic diseases and improving food safety

The market is segmented by product type, animal type, and distribution channel, with pharmaceuticals and vaccines representing the largest product categories. Geographically, China and Japan are the most mature markets, while India and Southeast Asian countries like Vietnam and Indonesia are emerging as high-growth regions. Livestock animals currently account for a larger share of the market by value, though companion animal healthcare is growing at a faster pace.

• •Pharmaceuticals and vaccines dominate product segments, followed by medicated feed additives
• •China, Japan, and Australia are leading regional markets; India and Southeast Asia showing fastest growth
• •Livestock segment holds larger share, while companion animal segment is expanding rapidly

What are the recent trends and outlook?

Digital veterinary services, telemedicine platforms, and pet health monitoring technologies are emerging as new growth areas, particularly in urban centers. The market is expected to continue its upward trajectory through 2030, supported by ongoing economic development, increased veterinary education, and the expanding footprint of multinational companies. Future growth will likely be driven by innovation in biologics and vaccines, along with greater emphasis on preventive healthcare over reactive treatment approaches.

• •Digital and telemedicine services for pets gaining traction in urban markets
• •Preventive healthcare and wellness programs becoming more mainstream among pet owners
• •Market projected to maintain 8-9% annual growth through 2030 with expanding access in rural areas